Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000223617 | SCV000268940 | benign | not specified | 2014-10-31 | criteria provided, single submitter | clinical testing | c.1821TCC[10] in exon 16 of DIAPH1: This allele is a part of a poly TCC stretch and is not expected to have clinical significance because it has been identified in 13% (994/7732) of European American chromosomes and 11% (411/3592) of Africa n American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.wash ington.edu/EVS/; dbSNP rs35249032). |
Prevention |
RCV000223617 | SCV000310905 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Eurofins Ntd Llc |
RCV000223617 | SCV000340968 | benign | not specified | 2016-04-12 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000600201 | SCV000745443 | benign | Autosomal dominant nonsyndromic hearing loss 1 | 2015-08-28 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001522464 | SCV001732017 | benign | Autosomal dominant nonsyndromic hearing loss 1; Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001538893 | SCV001756608 | benign | not provided | 2017-09-12 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000600201 | SCV000734382 | benign | Autosomal dominant nonsyndromic hearing loss 1 | no assertion criteria provided | clinical testing |